NMPA Approval

Compound Aminophenazone and Barbital Injection

Approval Number

国药准字H22025926

Company吉林敖东药业集团延吉股份有限公司

Registration Date

January 4, 2024

Drug Information

Generic Name

复方氨林巴比妥注射液

Dosage Form

注射剂

Strength

2ml：氨基比林0.1g，安替比林40mg，巴比妥18mg

Drug Type

化学药品

Registration Date

January 4, 2024

Company Information

Applicant Company

Company Name吉林敖东药业集团延吉股份有限公司

Company Address

吉林省延吉市高新技术开发区长白路389号

Manufacturing Company

Company Name吉林敖东药业集团延吉股份有限公司

Company Address

吉林省延吉市高新技术开发区长白路389号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

复方氨林巴比妥注射液 - NMPA 批准文号 | MedPath